Novo Holdings A/S’s Cymabay Therapeutics CBAY Stock Holding History

Novo Holdings A/S’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-900,000	Closed	-$21.3M	–	41
2023 Q4	$21.3M	Sell	900,000 -666,521	-43%	-$11.9M	1.31%	26
2023 Q3	$23.4M	Sell	1,566,521 -433,479	-22%	-$5.75M	1.73%	23
2023 Q2	$21.9M	Buy	+2,000,000	New	+$18.6M	1.69%	20

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Novo Holdings A/S's CBAY Position: Q1 2024 in Review

Novo Holdings A/S sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 900,000 shares — an estimated $21.3M sold.

Novo Holdings A/S first reported a position in CBAY in Q2 2023 and held it in 3 quarters. The position peaked at $23.4M in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Novo Holdings A/S reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Novo Holdings A/S sold 900,000 Cymabay Therapeutics shares in Q1 2024, an estimated $21.3M.
Novo Holdings A/S first reported a position in Cymabay Therapeutics in Q2 2023 and held it in 3 quarters.
Novo Holdings A/S's Cymabay Therapeutics position peaked at $23.4M in Q3 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Novo Holdings A/S's 13F filing for Q1 2024, filed 15 May 2024.